Invited Speaker | Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials
Dr. Chan has over 17 years of clinical development and medical affairs experience in the pharmaceutical industry and is currently the Head of Dermatology Medical Affairs at Janssen Immunology. She is responsible for leading a team of clinicians and scientists who conduct Phase 3/4 clinical trials designed to address unmet needs in the post-approval setting, contribute insights to inform Phase 2/3 clinical development programs of new investigational therapies and execute other scientific initiatives to increase disease awareness and broadly communicate new data and evidence that can help inform clinical practice. Dr. Chan completed her undergraduate training in Human Biology and Toxicology, and her doctoral training in Clinical Pharmacology at the University of Toronto, Canada.
Click here for more information on the Valeant Research Award.
Read published peer-reviewed articles written your by Skin of Color Society members
Did You Know
Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.
By 2042, more than 50% of the US population will have skin of color.